Literature DB >> 6542576

Effect of D-thyroxine on serum sex hormone binding globulin (SHBG), testosterone, and pituitary-thyroid function in euthyroid subjects.

S Yosha, M Fay, C Longcope, L E Braverman.   

Abstract

Concentrations of serum sex hormone binding globulin (SHBG) and free testosterone (T) were examined in 10 euthyroid subjects (5 men and 5 women) before, during and after 30 days of the daily ingestion of 1 or 4 mg D-thyroxine (D-T4), the thyroxine analog that has only 1-15% of the calorigenic effect of L-thyroxine (L-T4). No changes in serum L-T4 or triiodothyronine (T3), serum cholesterol, SHBG, T, progesterone, estradiol-17 beta, or free T concentrations were observed in response to the 1 mg dose, but there was a slight elevation in the free thyroxine index (FTI) and a significant (p less than 0.02) suppression of the thyrotropin (TSH) response to thyrotropin releasing hormone (TRH). The 4 mg dose of D-T4 induced an increase in SHBG levels in all but one man. There was a significant negative correlation between the SHBG and percent free T (p less than 0.05) although the mass of free T did not change. As a group, the women responded with a greater increase in SHBG and decrease in percent free T than the men. Serum cholesterol decreased (p less than 0.01), all serum thyroid hormone values measured by RIA were increased (p less than 0.01), and the TSH response to TRH was completely suppressed. Despite these changes, the subjects remained clinically euthyroid. Concentrations of testosterone, progesterone and estradiol-17 beta remained unchanged. Serum luteinizing hormone (LH), which was evaluated in the men only, also did not change during the daily administration of 4 mg D-T4.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6542576     DOI: 10.1007/BF03348455

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  27 in total

1.  METABOLISM OF D-THYROXINE.

Authors:  E V FLOCK; C DAVID; G A HALLENBECK; C A OWEN
Journal:  Endocrinology       Date:  1963-12       Impact factor: 4.736

2.  Physiological disposition of D- and L-thyroxine in the rat.

Authors:  D F TAPLEY; F F DAVIDOFF; W B HATFIELD; J E ROSS
Journal:  Am J Physiol       Date:  1959-11

3.  The effects of synthetic estrogens on the metabolic clearance and production rates of estrone and estradiol.

Authors:  C Longcope; D Watson; K I Williams
Journal:  Steroids       Date:  1974-07       Impact factor: 2.668

4.  Dextrothyroxine for lowering serum cholesterol. Analysis of data on 6066 patients.

Authors:  L D Bechtol; W L Warner
Journal:  Angiology       Date:  1969-11       Impact factor: 3.619

5.  Studies of the protein binding of testosterone in plasma in disorders of thyroid function: effect of therapy.

Authors:  J Olivo; A L Southren; G G Gordon; S Tochimoto
Journal:  J Clin Endocrinol Metab       Date:  1970-11       Impact factor: 5.958

6.  Sex hormone binding globulin capacity as an index of oestrogenicity or androgenicity in women on oral contraceptive steroids.

Authors:  M N El Makhzangy; V Wynn; D M Lawrence
Journal:  Clin Endocrinol (Oxf)       Date:  1979-01       Impact factor: 3.478

7.  Normalized androgen ratio: an index of free 17beta-hydroxysteroid concentration in serum.

Authors:  J M Gilliland; T C Smeaton; K Rowland
Journal:  Clin Chem       Date:  1978-09       Impact factor: 8.327

8.  Solid phase method for measurement of the binding capacity of testosterone-estradiol binding globulin in human serum.

Authors:  B C Nisula; D L Loriaux; Y A Wilson
Journal:  Steroids       Date:  1978-05       Impact factor: 2.668

9.  Radioimmunoassay of plasma progesterone.

Authors:  G E Abraham; R Swerdloff; D Tulchinsky; W D Odell
Journal:  J Clin Endocrinol Metab       Date:  1971-05       Impact factor: 5.958

10.  Comparative effectiveness of dextrothyroxine and levothyroxine in correcting hypothyroidism and lowering blood lipid levels in hypothyroid patients.

Authors:  C A Gorman; N S Jiang; R D Ellefson; L R Elveback
Journal:  J Clin Endocrinol Metab       Date:  1979-07       Impact factor: 5.958

View more
  2 in total

1.  Dissociated thyromimetic effects of 3, 5, 3'-triiodothyroacetic acid (TRIAC) at the pituitary and peripheral tissue levels.

Authors:  P Beck-Peccoz; A Sartorio; C De Medici; G Grugni; F Morabito; G Faglia
Journal:  J Endocrinol Invest       Date:  1988-02       Impact factor: 4.256

2.  Acute and chronic effects of dextro-thyroxine on pituitary thyroid axis and on reverse triiodothyronine production in euthyroid subjects.

Authors:  B Busnardo; N Simioni; M E Girelli; T Rampazzo; A Pagnan; G Zanetti; S Dotto; N Ciuccio
Journal:  J Endocrinol Invest       Date:  1987-02       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.